QUAKER CHEMICAL CORPORATION Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed
QUAKER CHEMICAL CORPORATION (KWR) reported Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed of $18.60 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed · last filed 2022-03-01
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2020-12-31 was $6.90M, a 42.98% decline year-over-year.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2020-09-30 was $6.90M, a 54.30% decline year-over-year.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2020-06-30 was $8.30M, a 50.91% increase year-over-year.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2020-03-31 was $8.30M, a 56.60% increase year-over-year.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2021 was $18.60M, a 38.61% decline from fiscal 2020.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2020 was $30.30M, a 20.26% decline from fiscal 2019.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2019 was $38.00M, a 94.87% increase from fiscal 2018.
- QUAKER CHEMICAL CORPORATION business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2018 was $19.50M, a 36.69% decline from fiscal 2017.
| Period end | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 3 month | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 6 month | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 9 month | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 12 month |
|---|---|---|---|---|
| 2021-12-31 | $18.60M 10-K · filed 2022-03-01 | |||
| 2020-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $13.80M derived: sum of 2 quarters · filed 2022-03-01 | $22.10M derived: sum of 3 quarters · filed 2022-03-01 | $30.30M 10-K · filed 2022-03-01 |
| 2020-09-30 | $6.90M 10-Q · filed 2020-11-05 | $15.20M derived: sum of 2 quarters · filed 2020-11-05 | $23.40M 10-Q · filed 2020-11-05 | $35.60M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $8.30M 10-Q · filed 2020-08-05 | $16.50M 10-Q · filed 2020-08-05 | $28.70M derived: sum of 3 quarters · filed 2022-03-01 | $43.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $8.30M 10-Q · filed 2020-05-11 | $20.40M derived: sum of 2 quarters · filed 2022-03-01 | $35.50M derived: sum of 3 quarters · filed 2022-03-01 | $41.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $27.20M derived: sum of 2 quarters · filed 2022-03-01 | $32.70M derived: sum of 3 quarters · filed 2022-03-01 | $38.00M 10-K · filed 2022-03-01 |
| 2019-09-30 | $15.10M 10-Q · filed 2020-11-05 | $20.60M derived: sum of 2 quarters · filed 2020-11-05 | $25.90M 10-Q · filed 2020-11-05 | $31.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $5.50M 10-Q · filed 2020-08-05 | $10.80M 10-Q · filed 2020-08-05 | $15.90M derived: sum of 3 quarters · filed 2021-03-01 | $19.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $5.30M 10-Q · filed 2020-05-11 | $10.40M derived: sum of 2 quarters · filed 2021-03-01 | $14.20M derived: sum of 3 quarters · filed 2021-03-01 | $18.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $8.90M derived: sum of 2 quarters · filed 2021-03-01 | $13.40M derived: sum of 3 quarters · filed 2021-03-01 | $19.50M 10-K · filed 2021-03-01 |
| 2018-09-30 | $3.80M 10-Q · filed 2019-11-12 | $8.30M derived: sum of 2 quarters · filed 2019-11-12 | $14.40M 10-Q · filed 2019-11-12 | $22.10M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $4.50M 10-Q · filed 2019-08-01 | $10.60M 10-Q · filed 2019-08-01 | $18.30M derived: sum of 3 quarters · filed 2019-08-01 | $28.00M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $6.10M 10-Q · filed 2019-05-02 | $13.80M derived: sum of 2 quarters · filed 2019-05-02 | $23.50M derived: sum of 3 quarters · filed 2019-05-02 | $27.80M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $17.40M derived: sum of 2 quarters · filed 2019-02-28 | $21.70M derived: sum of 3 quarters · filed 2019-02-28 | $30.80M 10-K · filed 2019-02-28 |
| 2017-09-30 | $9.70M 10-Q · filed 2018-11-01 | $14.00M derived: sum of 2 quarters · filed 2018-11-01 | $23.10M 10-Q · filed 2018-11-01 | $23.40M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $4.30M 10-Q · filed 2018-07-30 | $13.40M 10-Q · filed 2018-07-30 | $13.70M derived: sum of 3 quarters · filed 2019-02-28 | $14.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $9.10M 10-Q · filed 2018-04-30 | $9.40M derived: sum of 2 quarters · filed 2019-02-28 | $10.60M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.50M derived: sum of 2 quarters · filed 2019-02-28 | $1.50M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $1.20M 10-Q · filed 2017-10-26 | $1.20M 10-Q · filed 2017-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VALVOLINE INC (VVV) | United States | $3.618B | 49.71 |